Diagnostics as a Service is usually sold on a customer's first test and paid for by their second, though the two look like the same product. A clinic that tests each customer once has to keep finding new customers, so the retest belongs in the business model rather than in the aftercare.
The difference is commercial, because a first test is a transaction where the customer buys a number they do not have yet. A retest is closer to a relationship, since the only thing they can buy the second time is the difference between two numbers, and you have the first one.
None of this is legal advice, so a lawyer working in medical or competition law should review your own contracts and your website before you sell a retest.
What makes a retest different from a first blood test?
A first panel is a product anybody can sell, because the customer has no history and no reason to prefer one supplier. A retest is a product only you can sell, because the comparison needs the earlier result, the same markers and ideally the same laboratory method behind both.
The customer is not returning out of loyalty, but because the second measurement is worth more to them once the first one exists.
What can a retest honestly show, and what can it not?
A retest shows whether a value moved and by how much, measured against how much that marker moves on its own. It cannot show that your programme caused the movement, because a before-and-after pair in one person has no comparison group and two well-understood effects push the second number around.
Say the smaller thing accurately rather than the larger thing loosely, because the customers who notice the difference are the ones who stay.
Regression to the mean in a longevity clinic
If you select people because a value was extreme, their second measurement tends to be closer to average even when nothing was done for them. Part of the first value was ordinary fluctuation, so the extreme reading was partly luck and the luck does not repeat1.
This matters commercially because longevity clinics select exactly that way. The customers who start a programme are usually the ones whose first panel showed something unusual, which is the precise situation where a second, better number would have appeared anyway.
Analytical and biological variation
Two more effects change every comparison you make. The measurement itself has imprecision, which is why German laboratories run internal quality control and take part in external quality assessment under the Bundesärztekammer guideline2. The person also varies, since their own level changes across a day and across a week.
Laboratory medicine handles this with a threshold, meaning a difference has to be larger than the combined variation before it counts as a real change. Estimates of how much each marker varies within the same person are published per marker in the EFLM biological variation database3.
Tell the customer the value, the change and how large a change has to be for this marker before anybody should believe it.
How often should a longevity clinic retest each marker?
Cadence follows the marker rather than the calendar, because a lipid marker and a genetic marker do not move on the same clock. An annual panel that repeats everything is easy to sell and wrong on most of its contents, since some of it cannot change and some of it changed weeks ago.
- A genetic result never changes, so selling it twice is a wasted charge and a trust problem you do not need.
- Blood lipids and glucose handling respond over weeks to months, so a retest booked sooner than that mostly measures variation.
- Nutrient status follows the dose and the substance, so the interval belongs to the supplement rather than to the calendar.
- Hormones change within a single day, so the time of the draw matters more than the number of weeks between draws.
- Inflammatory markers respond to any infection, so a panel taken during a cold describes the cold.
- The microbiome changes within days of a diet change, although what the change means is still argued about.
The rule that keeps this honest is to retest what you acted on, plus a small stable core that gives the trend a shape. Everything else belongs in the catalogue rather than in the repeat schedule.
How should a longevity clinic package the retest?
Put the retest inside a membership where the markers repeat on a schedule, and sell it separately where the customer is following one specific question. Those two shapes produce different revenue and different work, so choose deliberately rather than offering both to everybody at once.
A membership works when a stable core of markers is worth repeating for most of your list, because the customer pays on a schedule and your team can plan the collection weeks. The risk is that a schedule invites you to repeat markers nobody acted on, which is the practice that makes a customer feel sold to.
A separate retest works when the second panel answers a question the first one raised, since the reason for buying is obvious and the customer chooses the timing. The risk is that nobody chooses it, because a retest with no prompt behind it competes with everything else in that person's month.
- Write the retest into the first conversation, so the customer expects a second panel before they pay for the first.
- Name the interval per marker in the report itself, rather than leaving the customer to ask when.
- Keep the second panel's markers narrow enough that the comparison is readable on one screen.
What does repeat testing cost a clinic to run in-house?
Repeat testing multiplies every operational weakness a clinic already has, because each repeat is a full event rather than a follow-up email. An appointment, a trained person, consumables, transport, an accredited analysis, quality control, a result and an explanation happen again every single time.
The part founders miss is the history. A trend across panels only works when the markers, the units and ideally the method are the same each time. Changing laboratory between panels can move a customer's line for a reason nobody in your clinic can explain to them.
What Diagnostics as a Service changes about the repeat testing cost
One accredited chain across every repeat keeps the comparison clean, and a partner arrangement charges you per panel rather than per month of idle capacity. Analysis is performed by an accredited laboratory partner, which holds ISO 15189 accreditation and operates under RiliBAEK4. Aniva runs 25+ partner draw locations across Germany and gives the customer a trend view across repeated panels inside your own white-label dashboard. The partner offering is sold across Europe, while the consumer membership and the physical draw network are in Germany.
The draw network is the piece that decides whether a retest actually happens. A customer who has to come back to your clinic for a second sample cancels more often than one who books a collection near their office. The second panel is therefore an operations problem before it is a marketing problem.
What does a trend view across repeated panels give a customer?
The customer returns for the line rather than for the number. One panel gives a value they cannot interpret alone, while three panels give a direction, and the direction is the only part of this that answers the question they actually had about themselves.
Everything in the Aniva customer dashboard is built around that, with plain-language explanations per marker, a trend view across repeated panels and a customer-facing PDF, all carrying your logo, your colours and your domain. The comparison belongs to your brand, which is what makes the next panel yours to sell.
What are retention numbers from testing vendors worth?
Several testing suppliers publish retention improvements they attribute to adding blood testing to a subscription. Treat those as vendor claims produced from vendor data, because none of them was audited, none describes your customers, and none tells you what your own second-panel rate would be.
You do not need a borrowed number to make this decision. Measure three of your own instead, and you will know more after two quarters than any published figure could tell you.
- Count the share of customers who book a second panel within twelve months.
- Count the median number of months between a customer's first and second panel.
- Count revenue per customer per year rather than revenue per panel sold.
Aniva needs four weeks between a signed contract and the first draw, so a retest cohort can exist inside the same year you start. Book a 30-minute demo at anivahealth.com/diagnostics and ask to see the trend view with repeated panels in it.
Notes and sources
Last updated: 31 August 2026
-
Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. International Journal of Epidemiology 2005;34(1):215 to 220. doi.org/10.1093/ije/dyh299
-
Bundesärztekammer, Richtlinie zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen (RiliBAEK). bundesaerztekammer.de
-
European Federation of Clinical Chemistry and Laboratory Medicine, Biological Variation Database, searchable per marker. EFLM Biological Variation Database homepage
-
ISO 15189:2022, Medical laboratories, requirements for quality and competence. iso.org
